Psychotropics and COVID-19: An analysis of safety and prophylaxis
Abstract The use of psychotropics during the COVID-19 pandemic has raised two questions, in order of importance: first, what changes…
psychotropics
Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer’s Dementia: A Clinical Case Report
Abstract Alzheimer’s Dementia (AD) is a devastating neurodegenerative disease that affects approximately 17% of people aged 75–84. Neuropsychiatric symptoms (NPS)…